Cargando…
Disease activity in COPD: time to make imaging biomarkers a PET project?
FDG uptake on PET/CT is a potential biomarker of pulmonary inflammation in COPD and may reflect disease activity, but does it have the characteristics of a “good” biomarker? https://bit.ly/3AXheEZ
Autores principales: | Milne, Stephen, Eddy, Rachel L., Sin, Don D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405865/ https://www.ncbi.nlm.nih.gov/pubmed/34476244 http://dx.doi.org/10.1183/23120541.00445-2021 |
Ejemplares similares
-
Computed Tomography Vascular Tree-in-Bud: A Novel Prognostic Imaging
Biomarker in COVID-19?
por: Eddy, Rachel L., et al.
Publicado: (2020) -
Exploring Mechanisms in COPD: Time for Biomarker Reappraisal?
por: Voulgareli, Ilektra, et al.
Publicado: (2023) -
COVID-19 and COPD
por: Leung, Janice M., et al.
Publicado: (2020) -
Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis
por: Guinto, Elizabeth, et al.
Publicado: (2023) -
Are blood eosinophils a prime-time biomarker for COPD management decisions?
por: Tsiligianni, Ioanna, et al.
Publicado: (2018)